𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Release of Proteins and Peptides from Fusion Proteins Using a Recombinant Plant Virus Proteinase

✍ Scribed by T.D. Parks; K.K. Leuther; E.D. Howard; S.A. Johnston; W.G. Dougherty


Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
390 KB
Volume
216
Category
Article
ISSN
0003-2697

No coin nor oath required. For personal study only.

✦ Synopsis


An improved method for the production, cleavage, and purification of fusion proteins and peptides is described. The unique aspect of this method is dependent on the use of a proteinase from tobacco etch virus (TEV). The proteinase used is a recombinant TEV proteinase produced with a polyhistidine tract positioned at the amino terminus. The proteinase recognizes a specific, extended cleavage site sequence. The peptide or protein of interest is purified as a fusion protein with a TEV proteinase cleavage site sequence located between it and an affinity carrier portion of the fusion. Incubation with the recombinant TEV proteinase mediates release of the peptide or protein of interest. Use of the recombinant TEV proteinase to cleave fusion proteins is an improvement over use of other proteinases for several reasons, including its high degree of specificity, its insensitivity to many proteinase inhibitors generally used in protein purification, and the ready separation of both the affinity tag and the proteinase from the cleaved product of interest. c 1994 Academic Press, Inc.


πŸ“œ SIMILAR VOLUMES


Comparison of recombinant human immunode
✍ R.L. Shoeman; D. Young; R. Pottathil; J. Victor; R.R. Conroy; R.M. Crowl; T. Col πŸ“‚ Article πŸ“… 1987 πŸ› Elsevier Science 🌐 English βš– 1006 KB

Diagnostic reagents for detection of human immunodeficiency virus (HIV) exposure with improved reliability may be provided by viral encoded proteins produced by recombinant DNA techniques or by synthetic peptides corresponding to appropriate viral epitopes. We have expressed at high levels in E. col

Viral specificity of hepatitis E virus a
✍ Michael A. Purdy; Dorrie Carson; Karen A. McCaustland; Daniel W. Bradley; Michae πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 351 KB

## Abstract A fluorescent antibody (FA) assay for hepatitis E virus antigen (HEVAg) in infected liver tissue was used to confirm the presence of virus‐specific antigens in hepatocytes during the course of infection. With the cloning of the HEV genome it is now possible to determine which viral anti

Expression of recombinant Norwalk-like v
✍ Yoda, T.; Terano, Y.; Shimada, A.; Suzuki, Y.; Yamazaki, K.; Sakon, N.; Oishi, I πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 380 KB πŸ‘ 1 views

The capsid protein of Norwalk-like virus (NLV) isolates NLV-36 (Mexico virus type, genogroup II [GII]), NLV-21 (Lordsdale virus type, GII), , and NLV-96-908 (KY89 virus type, GI) have been expressed in an Escherichia coli system. The expressed recombinant NLV capsid proteins, fused with maltose bind

Enhancement of gene delivery to human ai
✍ John W. Wiseman; Emily S. Scott; Paul A. Shaw; William H. Colledge πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 276 KB πŸ‘ 2 views

## Abstract ## Background Current liposome‐based gene delivery methods for therapeutic benefit are limited by their low efficiency. One possible way to improve gene expression is to include a peptide with a nuclear localization signal (NLS) to enhance the movement of the transfection complex from